 | Related Articles |
Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.
Hematol Oncol Clin North Am. 2017 Apr;31(2):255-272
Authors: Dittus C, Sloan JM
Abstract
Adult T-cell leukemia/lymphoma (ATLL) is a rare T-cell disorder that is etiologically linked to chronic infection with human T-cell lymphotropic virus type 1. ATLL is divided into four subtypes: acute, lymphomatous, chronic, and smoldering. The acute and lymphomatous variants are often described clinically as the aggressive types of ATLL. Treatment strategies traditionally have focused on antiviral therapy with zidovudine and interferon-alpha and combination chemotherapy. Novel therapeutic approaches include the use of monoclonal antibodies, anti-CCR4 therapy, immunomodulatory therapy, and anti-TAX vaccines. Future research must focus on multi-institutional clinical trial participation because of the rarity of this deadly hematologic malignancy.
PMID: 28340877 [PubMed - indexed for MEDLINE]
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2r6YWzl
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου